Evidence map›Paper›PMID 41078578›Full record

ArticleMolecular genetics and metabolism reports2025

Case report: Lysine improvement in siblings with glutaric acidemia type 1 following reduced medical food intake: Implications for amino acid absorption and reabsorption.

Grace Noh, Jariya Upadia

Abstract readCase Reports
In one paragraph

Article in Molecular genetics and metabolism reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Grace NohHayward Genetics Center, USA.
Jariya UpadiaHayward Genetics Center, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutaric acidemia type 1 (GA1) is a rare metabolic disorder requiring dietary management with lysine (Lys)-free, tryptophan (Trp)-reduced, and arginine (Arg)-fortified medical formulas. This case report describes three siblings with GA1 who exhibited persistently low plasma lysine levels despite meeting age-appropriate dietary protein intake from intact protein sources. Upon reducing medical formula intake while maintaining intact protein consumption, lysine levels normalized, suggesting that excess dietary arginine may inhibit lysine intestinal uptake or reabsorption in the kidneys. These findings highlight the need for further research on amino acid interactions in GA1 dietary management and emphasize careful formula prescription to prevent unintended lysine deficiency.

Indexed as

Arginine-fortified formulaCationic amino acid transportersDietary protein intakeGlutaric acidemia type 1Lysine absorptionLysine-free formulaLysine reabsorption

Identifiers

PMID41078578
PMCPMC12513105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.